Deep Track Capital, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001856083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2025 · 65 positions · Total reported value $3.11B · Top-10 concentration 52.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 59.3% · 18 new · 15 cut · 15 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +27.7% · vs SPY +12.9% · Prev Value $6.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2025 13F filing, Deep Track Capital, LP disclosed 65 equity positions with a combined reported value of $3.11B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 52.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were GH ($221.17M), IONS ($193.26M), PTGX ($179.40M). By sector, the heaviest allocations are Health Care 78.4%, Other 21.6%. Versus the prior quarter, allocation shifted toward Health Care (+8.0pp) and away from Other (-8.0pp).

Versus the prior quarter, Deep Track Capital, LP opened 18 new positions, trimmed 15 and fully exited 15, a turnover rate of 59.3% of positions. The portfolio's overlap with the prior quarter was 79% of names.

The largest new positions opened in Q2 2025 were AXSM ($83.66M), JBIO ($25.07M), MRUS ($14.46M).

Of the 15 positions fully exited versus the prior quarter, the largest were ITCI ($263.84M), AMGN ($35.22M), EWTX ($30.80M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • AXSM AXSOME THERAPEUTICS INC. · $83.66M
  • JBIO JADE BIOSCIENCES INC · $25.07M
  • MRUS MERUS N V · $14.46M
  • CDTX CIDARA THERAPEUTICS INC · $12.18M
  • CBIO CRESCENT BIOPHARMA INC. · $7.32M
  • CNTA CENTESSA PHARMACEUTICALS PLC · $6.57M

Fully Exited (vs previous quarter)

  • ITCI INTRA-CELLULAR THERAPIES INC · prev qtr: $263.84M
  • AMGN AMGEN INC · prev qtr: $35.22M
  • EWTX EDGEWISE THERAPEUTICS INC · prev qtr: $30.80M
  • DYN DYNE THERAPEUTICS INC · prev qtr: $20.92M · history
  • LKFT LAKEFRONT BIOTHERAPEUTICS NV · prev qtr: $18.62M
  • SAGE SAGE THERAPEUTICS INC · prev qtr: $16.21M
  • BEAM BEAM THERAPEUTICS INC · prev qtr: $6.17M · history
  • RGLS REGULUS THERAPEUTICS INC · prev qtr: $5.71M

Insider Transactions (Form 4)

Latest Deep Track Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 1,957,138 — SEC filing

All insider transactions →

Fund Profile

Deep Track Capital, LP is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 66 US equity positions with a combined value of $6.72B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-120500 (status: Approved), registered 2021-03-12
  • Regulatory AUM (Form ADV): $8.37B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: deeptrackcapital.com

Portfolio Structure

  • 66 positions · $6.72B reported value (Q2 2026)
  • Top 10 holdings = 40.5% of reported value
  • Largest position: GH (GUARDANT HEALTH INC) at 7.6%
  • Average position size: $101.75M

Sector Tilt

  • Health Care 95.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 18 new, 20 added, 15 reduced, 15 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 78.4%
Other 21.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 4.25M $221.17M 7.11%
7.11%
Reduce
2 4.89M $193.26M 6.21%
6.21%
Add
3 3.25M $179.40M 5.77%
5.77%
Add
4 17.79M $176.49M 5.67%
5.67%
Hold
5 1.75M $176.12M 5.66%
5.66%
Add
6 3.04M $162.35M 5.22%
5.22%
Reduce
7 9.50M $152.00M 4.89%
4.89%
Hold
8 14.29M $132.65M 4.26%
4.26%
Hold
9 7.00M $121.17M 3.90%
3.90%
Add
10 3.65M $120.60M 3.88%
3.88%
Add
11 5.13M $106.48M 3.42%
3.42%
Add
12 9.50M $93.29M 3.00%
3.00%
Add
13 801.37K $83.66M 2.69%
2.69%
New
14 5.38M $75.22M 2.42%
2.42%
Hold
15 1.75M $70.89M 2.28%
2.28%
Add
16 2.15M $69.90M 2.25%
2.25%
Add
17 6.06M $69.08M 2.22%
2.22%
Add
18 43.00M $60.63M 1.95%
1.95%
Add
19 1.80M $56.48M 1.82%
1.82%
Add
20 1.35M $49.09M 1.58%
1.58%
Hold
21 3.95M $48.45M 1.56%
1.56%
Add
22 700.00K $45.67M 1.47%
1.47%
Hold
23 1.35M $42.26M 1.36%
1.36%
Add
24 2.23M $41.60M 1.34%
1.34%
Reduce
25 2.00M $40.70M 1.31%
1.31%
Hold
26 900.00K $38.86M 1.25%
1.25%
Reduce
27 16.85M $38.42M 1.24%
1.24%
Reduce
28 1.09M $31.14M 1.00%
1.00%
Hold
29 7.50M $27.96M 0.90%
0.90%
Add
30 1.40M $27.86M 0.90%
0.90%
Hold
31 3.48M $26.62M 0.86%
0.86%
Reduce
32 2.51M $25.07M 0.81%
0.81%
New
33 2.19M $24.97M 0.80%
0.80%
Reduce
34 8.83M $24.73M 0.80%
0.80%
Hold
35 2.00M $24.38M 0.78%
0.78%
Hold
36 2.43M $22.54M 0.72%
0.72%
Add
37 1.92M $21.51M 0.69%
0.69%
Add
38 4.56M $16.59M 0.53%
0.53%
Hold
39 2.50M $16.23M 0.52%
0.52%
Hold
40 1.44M $15.84M 0.51%
0.51%
Reduce
41 3.44M $14.67M 0.47%
0.47%
Hold
42 275.00K $14.46M 0.47%
0.47%
New
43 1.53M $12.84M 0.41%
0.41%
Hold
44 250.00K $12.18M 0.39%
0.39%
New
45 1.20M $8.36M 0.27%
0.27%
Add
46 453.69K $7.32M 0.23%
0.23%
New
47 500.00K $6.57M 0.21%
0.21%
New
48 998.54K $6.29M 0.20%
0.20%
Reduce
49 8.59M $6.14M 0.20%
0.20%
Reduce
50 751.42K $6.01M 0.19%
0.19%
Reduce

FAQ

What did Deep Track Capital, LP buy in 2025-Q2?

In its 2025-Q2 13F filing, Deep Track Capital, LP reported 65 equity positions worth $3.11B in aggregate; its largest disclosed positions were GH ($221.17M), IONS ($193.26M), PTGX ($179.40M).

How large is Deep Track Capital, LP's portfolio?

Deep Track Capital, LP reported $3.11B of long equity holdings across 65 positions as of 2025-Q2. Top-10 holdings account for 52.6% of reported value.

What is Deep Track Capital, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deep-track-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →